# FDA Inspection 656042 - Enemeez, LLC dba Summit Pharmaceuticals - March 12, 2010

Source: https://www.globalkeysolutions.net/records/fda_inspections/enemeez-llc-dba-summit-pharmaceuticals/956789fb-e51c-4fc8-9706-d3394939db6e
Source feed: FDA_Inspections

> FDA Inspection 656042 for Enemeez, LLC dba Summit Pharmaceuticals on March 12, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 656042
- Company Name: Enemeez, LLC dba Summit Pharmaceuticals
- Inspection Date: 2010-03-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1302518 - 2026-02-12](https://www.globalkeysolutions.net/records/fda_inspections/enemeez-llc-dba-summit-pharmaceuticals/12a25bf5-77ce-4384-a93c-ff5f6e98e524)
- [FDA Inspection 1147428 - 2021-07-29](https://www.globalkeysolutions.net/records/fda_inspections/enemeez-llc-dba-summit-pharmaceuticals/7e7bbba6-611e-4478-a3de-f582c1b59bd4)
- [FDA Inspection 987440 - 2016-08-10](https://www.globalkeysolutions.net/records/fda_inspections/enemeez-llc-dba-summit-pharmaceuticals/dc80d110-051f-497b-9582-53e15040cdf4)
- [FDA Inspection 728243 - 2011-06-06](https://www.globalkeysolutions.net/records/fda_inspections/enemeez-llc-dba-summit-pharmaceuticals/992c79ea-0e09-490a-9175-027babbc7ae1)

Company: https://www.globalkeysolutions.net/companies/enemeez-llc-dba-summit-pharmaceuticals/dd1473a2-9b40-4ff6-a713-f83d1ba98c4f

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c